Parameters of the classical complement pathway predict disease severity in hereditary angioedema.

[1]  B. Berman.  Treatment of episodes of hereditary angioedema with C1 inhibitor: serial assessment of observed abnormalities of the plasma bradykinin-forming pathway and fibrinolysis , 2011 .

[2]  B. Zuraw.  The Pathophysiology of Hereditary Angioedema , 2010, The World Allergy Organization journal.

[3]  P. Keith,et al.  2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema , 2010, Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology.

[4]  H. Farkas,et al.  Baseline level of functional C1-inhibitor correlates with disease severity scores in hereditary angioedema. , 2010, Clinical immunology.

[5]  K. Bork,et al.  Hereditary angioedema: increased number of attacks after frequent treatments with C1 inhibitor concentrate. , 2009, The American journal of medicine.

[6]  A. Bellatorre,et al.  Plasma biomarkers of acute attacks in patients with angioedema due to C1‐inhibitor deficiency , 2009, Allergy.

[7]  K. Bork,et al.  Benefits and risks of danazol in hereditary angioedema: a long-term survey of 118 patients. , 2008, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[8]  M. López-Trascasa,et al.  Metallopeptidase activities in hereditary angioedema: effect of androgen prophylaxis on plasma aminopeptidase P. , 2008, The Journal of allergy and clinical immunology.

[9]  D. Rabczenko,et al.  Possible disease-modifying factors: the mannan-binding lectin pathway and infections in hereditary angioedema of children and adults , 2008, Archivum Immunologiae et Therapiae Experimentalis.

[10]  M. Frank.  8. Hereditary angioedema. , 2008, The Journal of allergy and clinical immunology.

[11]  Z. Rónai,et al.  Relationship between copy number of genes (C4A, C4B) encoding the fourth component of complement and the clinical course of hereditary angioedema (HAE). , 2007, Molecular immunology.

[12]  N. Monnier,et al.  Functional analysis of splicing mutations and of an exon 2 polymorphic variant of SERPING1/C1NH. , 2006, Human mutation.

[13]  K. Bork,et al.  Hereditary angioedema: new findings concerning symptoms, affected organs, and course. , 2006, The American journal of medicine.

[14]  J. Alsenz,et al.  The critical concentration of C1-esterase inhibitor (C1-INH) in human serum preventing auto-activation of the first component of complement (C1). , 2005, Molecular immunology.

[15]  William H. Yang,et al.  Canadian 2003 International Consensus Algorithm For the Diagnosis, Therapy, and Management of Hereditary Angioedema. , 2004, The Journal of allergy and clinical immunology.

[16]  A. Tordai,et al.  Hereditary and acquired angioedema: Problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyond , 2004, Journal of Allergy and Clinical Immunology.

[17]  H. Farkas,et al.  Sex hormones in hereditary angioneurotic oedema , 2004, Clinical endocrinology.

[18]  K. Kragballe,et al.  Hereditary Angioedema. , 2018, The New England journal of medicine.

[19]  R. Ziccardi.  The first component of human complement (C1): Activation and control , 2004, Springer Seminars in Immunopathology.

[20]  A. Tordai,et al.  Mutation screening of the C1 inhibitor gene among Hungarian patients with hereditary angioedema , 2003, Human mutation.

[21]  G. Füst,et al.  C1r-C1s-C1inhibitor (C1rs-C1inh) complex measurements in tears of patients before and after penetrating keratoplasty , 2002, Current Eye Research.

[22]  H. Farkas,et al.  Eradication of Helicobacter pylori and improvement of hereditary angioneurotic oedema , 2001, The Lancet.

[23]  M. Cicardi,et al.  Plasma bradykinin in angio-oedema , 1998, The Lancet.

[24]  T. Mollnes,et al.  A Neoepitope‐Based Enzyme Immunoassay for Quantification of C1‐Inhibitor in Complex with C1r and C1s , 1997, Scandinavian journal of immunology.

[25]  P. Mannucci,et al.  Activation of the coagulation cascade in C1-inhibitor deficiencies. , 1997, Blood.

[26]  E. Chan,et al.  Analysis of an exon 1 polymorphism of the B2 bradykinin receptor gene and its transcript in normal subjects and patients with C1 inhibitor deficiency. , 1997, The Journal of allergy and clinical immunology.

[27]  T. Mollnes,et al.  C3 is Activated in Hereditary Angioedema, and C1/C1‐Inhibitor Complexes Rise During Physical Stress in Untreated Patients , 1995, Scandinavian journal of immunology.

[28]  A. Eerenberg,et al.  Generation of plasmin during acute attacks of hereditary angioedema. , 1993, The Journal of laboratory and clinical medicine.

[29]  E. Hack,et al.  Long-term treatment of hereditary angioedema with attenuated androgens: a survey of a 13-year experience. , 1991, The Journal of allergy and clinical immunology.

[30]  E. Hack,et al.  Plasma levels of C1- inhibitor complexes and cleaved C1- inhibitor in patients with hereditary angioneurotic edema. , 1990, The Journal of clinical investigation.

[31]  E. Ritz,et al.  Fluid phase generation of terminal complement complex as a novel index of bioincompatibility. , 1990, Kidney international.

[32]  A. Agostoni,et al.  Inherited C1 inhibitor deficiency. , 1989, Complement and inflammation.

[33]  A. Davis.  C1 inhibitor and hereditary angioneurotic edema. , 1988, Annual review of immunology.

[34]  U. Mårtensson,et al.  C1 dissociation. Spontaneous generation in human serum of a trimer complex containing C1 inactivator, activated C1r, and zymogen C1s. , 1987, Journal of immunology.

[35]  N. Cooper.  The classical complement pathway: activation and regulation of the first complement component. , 1985, Advances in immunology.

[36]  A. Kaplan,et al.  Studies of complement autoactivatability in hereditary angioedema: direct relationship to functional C-1-INA and the effect of classical pathway activators. , 1984, Clinical immunology and immunopathology.

[37]  J. Dunn,et al.  Mechanisms of activation of the classical pathway of complement by Hageman factor fragment. , 1983, The Journal of clinical investigation.

[38]  J. Atkinson,et al.  Hereditary angioedema: the clinical syndrome and its management. , 1976, Annals of internal medicine.